海王生物
(000078)
| 流通市值：56.46亿 | | | 总市值：59.14亿 |
| 流通股本：26.26亿 | | | 总股本：27.51亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 28,640,393,734.42 | 19,953,807,547.43 | 9,957,850,383.56 | 37,834,858,745.02 |
| 营业收入 | 28,640,393,734.42 | 19,953,807,547.43 | 9,957,850,383.56 | 37,834,858,745.02 |
| 二、营业总成本 | 28,340,184,524.32 | 19,699,182,312.57 | 9,825,719,310.45 | 37,782,459,350.73 |
| 营业成本 | 25,683,929,041.52 | 17,863,525,109.91 | 8,893,421,597.94 | 34,045,035,123.5 |
| 税金及附加 | 77,711,143.67 | 51,968,260.54 | 26,569,221.57 | 103,778,159.81 |
| 销售费用 | 1,066,207,615.14 | 755,558,781.1 | 419,809,578.57 | 1,517,647,144.78 |
| 管理费用 | 887,488,612.86 | 599,008,672.98 | 293,625,771.96 | 1,162,353,093.59 |
| 研发费用 | 37,110,222.28 | 23,003,143.21 | 11,339,139.83 | 48,433,791.57 |
| 财务费用 | 587,737,888.85 | 406,118,344.83 | 180,954,000.58 | 905,212,037.48 |
| 其中:利息费用 | 629,652,016.9 | 430,468,506.4 | 232,447,093 | 930,858,502.07 |
| 其中:利息收入 | 67,936,638.4 | 42,349,602.06 | 32,683,125.05 | 65,473,197.24 |
| 加:公允价值变动收益 | 282,609.11 | 425,930.5 | - | 56,846,924.38 |
| 加:投资收益 | 25,825,105.42 | 24,393,439.49 | 26,343,723.41 | -143,504,603.62 |
| 资产处置收益 | 1,970,755.17 | 544,973.44 | 183,383.76 | 11,330,111.98 |
| 资产减值损失(新) | -2,918,418.39 | -117,095.77 | 2,602,811.96 | -550,405,974.06 |
| 信用减值损失(新) | -11,585,203.56 | -21,781,476.54 | -3,669,660.08 | -333,417,213.95 |
| 其他收益 | 15,597,715.04 | 13,310,278.52 | 9,109,245.77 | 52,163,736.01 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 329,381,772.89 | 271,401,284.5 | 166,700,577.93 | -854,587,624.97 |
| 加:营业外收入 | 19,368,772.99 | 13,060,253.32 | 4,798,781.27 | 30,866,307.11 |
| 减:营业外支出 | 6,794,257.59 | 4,463,964.72 | 2,246,676.77 | 29,438,182.91 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 341,956,288.29 | 279,997,573.1 | 169,252,682.43 | -853,159,500.77 |
| 减:所得税费用 | 155,946,988.51 | 116,020,010.98 | 59,002,207.19 | 138,971,848.49 |
| 六、净利润 | 186,009,299.78 | 163,977,562.12 | 110,250,475.24 | -992,131,349.26 |
| 持续经营净利润 | 186,009,299.78 | - | 110,250,475.24 | -992,131,349.26 |
| 归属于母公司股东的净利润 | 88,482,060.79 | 87,678,709.12 | 74,530,706.41 | -1,027,374,726.45 |
| 少数股东损益 | 97,527,238.99 | 76,298,853 | 35,719,768.83 | 35,243,377.19 |
| (一)基本每股收益 | 0.03 | 0.03 | 0.03 | -0.39 |
| (二)稀释每股收益 | 0.03 | 0.03 | 0.03 | -0.39 |
| 八、其他综合收益 | - | - | - | -8,422,495.77 |
| 归属于母公司股东的其他综合收益 | - | - | - | -8,422,495.77 |
| 九、综合收益总额 | 186,009,299.78 | 163,977,562.12 | 110,250,475.24 | -1,000,553,845.03 |
| 归属于母公司股东的综合收益总额 | 88,482,060.79 | 87,678,709.12 | 74,530,706.41 | -1,035,797,222.22 |
| 归属于少数股东的综合收益总额 | 97,527,238.99 | 76,298,853 | 35,719,768.83 | 35,243,377.19 |
| 公告日期 | 2023-10-30 | 2023-08-29 | 2023-04-28 | 2023-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |